Upgrade to SI Premium - Free Trial

CG Oncology, Inc. (CGON) Tops Q3 EPS by 12c

November 12, 2024 5:22 PM

CG Oncology, Inc. (NASDAQ: CGON) reported Q3 EPS of ($0.30), $0.12 better than the analyst estimate of ($0.42).

For earnings history and earnings-related data on CG Oncology, Inc. (CGON) click here.

Categories

Earnings